Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Preston, Noel W.
1979.
Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques.
p.
9.
Preston, Noel W.
Timewell, Roger M.
and
Carter, Edward J.
1980.
Experimental pertussis infection in the rabbit: Similarities with infection in primates.
Journal of Infection,
Vol. 2,
Issue. 3,
p.
227.
Preston, N W
1982.
Toxicity of pertussis vaccine..
BMJ,
Vol. 284,
Issue. 6332,
p.
1817.
Huovila, R
Kuronen, T
Jännes, L
and
Hallman, N.
1982.
AGGLUTININS IN CHILDREN VACCINATED WITH THE DPT VACCINES USED IN FINLAND, SEROTYPES OF BORDETELLA PERTUSSIS STRAINS ISOLATED DURING WHOOPING COUGH EPIDEMICS IN 1976–1977 AND WHOOPING COUGH ATTACK RATE IN CHILDREN IN THE EPIDEMIC AREAS..
Acta Paediatrica,
Vol. 71,
Issue. s298,
p.
21.
Preston, N. W.
Surapatana, Narekul
and
Carter, E. J.
1982.
A reappraisal of serotype factors 4, 5 and 6 ofBordetella pertussis.
Journal of Hygiene,
Vol. 88,
Issue. 1,
p.
39.
Kwantes, B. W.
Joynson, D. H. M.
and
Williams, W. O.
1983.
Bordetella pertussis isolation in general practice: 1977–79 whooping cough epidemic in West Glamorgan.
Journal of Hygiene,
Vol. 90,
Issue. 2,
p.
149.
Vervloet, D.
1983.
ANAPHYLACTOID REACTIONS TO SUXAMETHONIUM.
The Lancet,
Vol. 322,
Issue. 8360,
p.
1197.
Preston, NoelW.
1983.
PERTUSSIS ANTIBODIES IN VACCINATED CHILDREN.
The Lancet,
Vol. 322,
Issue. 8360,
p.
1197.
Preston, NoelW.
1984.
PERTUSSIS COMPONENT VACCINE IN JAPAN.
The Lancet,
Vol. 323,
Issue. 8374,
p.
456.
Hirschhorn, Norbert
1984.
NICOTINIC ACID TO REDUCE FLUID-LOSS IN CHOLERA.
The Lancet,
Vol. 323,
Issue. 8374,
p.
456.
Fine, Adrian
1984.
UNIVERSAL HOME HAEMODIALYSIS.
The Lancet,
Vol. 323,
Issue. 8374,
p.
456.
Hoppe, JörgE.
and
Preston, NoelW.
1985.
WHOOPING COUGH IN WEST GERMANY.
The Lancet,
Vol. 326,
Issue. 8458,
p.
776.
Preston, NoelW.
1985.
CHANGE IN SEROTYPE OF PERTUSSIS INFECTION IN BRITAIN.
The Lancet,
Vol. 325,
Issue. 8427,
p.
510.
Watanabe, Mitsuru
Nakase, Yasukiyo
Aoyama, Tatsuo
Ozawa, Hiroko
Murase, Yuji
and
Iwata, Takashi
1986.
Serotype and Drug Susceptibility of Bordetella pertussis Isolated in Japan from 1975 to 1984.
Microbiology and Immunology,
Vol. 30,
Issue. 5,
p.
491.
Enders, Gisela
Rapp, Ingrid
Biber, Marion
Preston, NoelW.
and
Carter, EdwardJ.
1988.
WHOOPING COUGH IN STUTTGART.
The Lancet,
Vol. 331,
Issue. 8594,
p.
1113.
Blaskett, Alan C.
and
Cox, John C.
1988.
Immunogenicity of specificBordetella pertussissurface antigens in diphtheria-tetanus-pertussis (DTP) vaccines.
Epidemiology and Infection,
Vol. 100,
Issue. 3,
p.
335.
Rutter, D.A.
Ashworth, L.A.E.
Day, A.
Funnell, S.
Lovell, F.
and
Robinson, A.
1988.
Trial of a new acellular pertussis vaccine in healthy adult volunteers.
Vaccine,
Vol. 6,
Issue. 1,
p.
29.
Robinson, A.
Gorringe, A.R.
Funnell, S.G.P.
and
Fernandez, M.
1989.
Serospecific protection of mice against intranasal infection with Bordetella pertussis.
Vaccine,
Vol. 7,
Issue. 4,
p.
321.
Miller, E.
Waight, P.A.
Ashworth, L.A.E.
Robinson, A.
and
Irons, L.I.
1991.
Phase II trial of whole-cell pertussis vaccine vs an acellular vaccine containing agglutinogens.
The Lancet,
Vol. 337,
Issue. 8733,
p.
70.
MacGregor, D.
Coote, J.G.
Duggleby, C.J.
and
Parton, R.
1991.
Serotype variation inBordetella pertussisis governed bycis-acting elements.
FEMS Microbiology Letters,
Vol. 78,
Issue. 2-3,
p.
333.